Decreasing CAMKK2 activity using pharmacological inhibition, or the depletion of CAMKK2 using small interfering RNA (siRNA), reduces cell proliferation, migration and invasion in several cancer types [16,54,55,56,57,58,59,60,62,63,64,65]. This evidence concerns the gene CAMKK2 and cancer.